Cargando…

Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia

Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Yu-Hsin, Hsieh, Meng-Ying, Lee, Wen-I, Huang, Jing-Long, Chen, Li-Chen, Yeh, Kuo-Wei, Ou, Liang-Shiou, Yao, Tsung-Chieh, Wu, Chao-Yi, Lin, Syh-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498534/
https://www.ncbi.nlm.nih.gov/pubmed/33013854
http://dx.doi.org/10.3389/fimmu.2020.02001
_version_ 1783583531610406912
author Yeh, Yu-Hsin
Hsieh, Meng-Ying
Lee, Wen-I
Huang, Jing-Long
Chen, Li-Chen
Yeh, Kuo-Wei
Ou, Liang-Shiou
Yao, Tsung-Chieh
Wu, Chao-Yi
Lin, Syh-Jae
author_facet Yeh, Yu-Hsin
Hsieh, Meng-Ying
Lee, Wen-I
Huang, Jing-Long
Chen, Li-Chen
Yeh, Kuo-Wei
Ou, Liang-Shiou
Yao, Tsung-Chieh
Wu, Chao-Yi
Lin, Syh-Jae
author_sort Yeh, Yu-Hsin
collection PubMed
description Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expression in patients suspected of having XLA who were referred from the Taiwan Foundation of Rare Disorders (TFRD). Methods: Patients with recurrent bacterial infections in the first 2 years of life, serum IgG/A/M below 2 standard deviations of the normal range, and ≦2% CD19+B cells were enrolled during the period of 2004–2019. The frequency of infections, pathogens, B-lymphocyte subsets, and family pedigree were recorded. Peripheral blood samples were sent to our institute for BTK expression and genetic analysis. Results: Nineteen (from 16 families) out of 29 patients had BTK mutations, including 7 missense mutations, 7 splicing mutations, 1 nonsense mutation, 2 huge deletions, and 2 nucleotide deletions. Six novel mutations were detected: c.504G>T [p.K168N], c.895-2A>G [p.Del K290 fs 23(*)], c.910T>G [p.F304V], c.1132T>C [p.T334H], c.1562A>T [p.D521V], and c.1957delG [Del p.D653 fs plus 45 a.a.]. All patients with BTK mutations had obviously decreased BTK expressions. Pseudomonas sepsis developed in 14 patients and led to both Shanghai fever and recurrent hemophagocytic lymphohistiocytosis (HLH). Recurrent sinopulmonary infections and bronchiectasis occurred in 11 patients. One patient died of pseudomonas sepsis and another died of hepatocellular carcinoma before receiving optimal treatment. Two patients with contiguous gene deletion syndrome (CGS) encompassing the TIMM8A/DDP1 gene presented with early-onset progressive post-lingual sensorineural Deafness, gradual Dystonia, and Optic Neuronopathy syndrome (DDON) or Mohr-Tranebjaerg syndrome (MTS). Conclusion: Pseudomonas sepsis was more common (74%) than recurrent sinopulmonary infections in Taiwanese XLA patients, and related to Shanghai fever and recurrent HLH, both of which were prevented by regular immunoglobulin infusions. Approximately 10% of patients belonged to CGS involving the TIMM8A/DDP1 gene and presented with the DDON/MTS phenotype in need of aggressive psychomotor therapy.
format Online
Article
Text
id pubmed-7498534
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74985342020-10-02 Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia Yeh, Yu-Hsin Hsieh, Meng-Ying Lee, Wen-I Huang, Jing-Long Chen, Li-Chen Yeh, Kuo-Wei Ou, Liang-Shiou Yao, Tsung-Chieh Wu, Chao-Yi Lin, Syh-Jae Front Immunol Immunology Background: X-linked agammaglobulinemia (XLA) is caused by a mutation of the Bruton's tyrosine kinase (BTK) gene and is the most common genetic mutation in patients with congenital agammaglobulinemia. The aim of this study was to analyze the clinical features, genetic defects, and/or BTK expression in patients suspected of having XLA who were referred from the Taiwan Foundation of Rare Disorders (TFRD). Methods: Patients with recurrent bacterial infections in the first 2 years of life, serum IgG/A/M below 2 standard deviations of the normal range, and ≦2% CD19+B cells were enrolled during the period of 2004–2019. The frequency of infections, pathogens, B-lymphocyte subsets, and family pedigree were recorded. Peripheral blood samples were sent to our institute for BTK expression and genetic analysis. Results: Nineteen (from 16 families) out of 29 patients had BTK mutations, including 7 missense mutations, 7 splicing mutations, 1 nonsense mutation, 2 huge deletions, and 2 nucleotide deletions. Six novel mutations were detected: c.504G>T [p.K168N], c.895-2A>G [p.Del K290 fs 23(*)], c.910T>G [p.F304V], c.1132T>C [p.T334H], c.1562A>T [p.D521V], and c.1957delG [Del p.D653 fs plus 45 a.a.]. All patients with BTK mutations had obviously decreased BTK expressions. Pseudomonas sepsis developed in 14 patients and led to both Shanghai fever and recurrent hemophagocytic lymphohistiocytosis (HLH). Recurrent sinopulmonary infections and bronchiectasis occurred in 11 patients. One patient died of pseudomonas sepsis and another died of hepatocellular carcinoma before receiving optimal treatment. Two patients with contiguous gene deletion syndrome (CGS) encompassing the TIMM8A/DDP1 gene presented with early-onset progressive post-lingual sensorineural Deafness, gradual Dystonia, and Optic Neuronopathy syndrome (DDON) or Mohr-Tranebjaerg syndrome (MTS). Conclusion: Pseudomonas sepsis was more common (74%) than recurrent sinopulmonary infections in Taiwanese XLA patients, and related to Shanghai fever and recurrent HLH, both of which were prevented by regular immunoglobulin infusions. Approximately 10% of patients belonged to CGS involving the TIMM8A/DDP1 gene and presented with the DDON/MTS phenotype in need of aggressive psychomotor therapy. Frontiers Media S.A. 2020-09-04 /pmc/articles/PMC7498534/ /pubmed/33013854 http://dx.doi.org/10.3389/fimmu.2020.02001 Text en Copyright © 2020 Yeh, Hsieh, Lee, Huang, Chen, Yeh, Ou, Yao, Wu and Lin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Yeh, Yu-Hsin
Hsieh, Meng-Ying
Lee, Wen-I
Huang, Jing-Long
Chen, Li-Chen
Yeh, Kuo-Wei
Ou, Liang-Shiou
Yao, Tsung-Chieh
Wu, Chao-Yi
Lin, Syh-Jae
Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
title Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
title_full Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
title_fullStr Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
title_full_unstemmed Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
title_short Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia
title_sort distinct clinical features and novel mutations in taiwanese patients with x-linked agammaglobulinemia
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498534/
https://www.ncbi.nlm.nih.gov/pubmed/33013854
http://dx.doi.org/10.3389/fimmu.2020.02001
work_keys_str_mv AT yehyuhsin distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT hsiehmengying distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT leeweni distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT huangjinglong distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT chenlichen distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT yehkuowei distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT ouliangshiou distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT yaotsungchieh distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT wuchaoyi distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia
AT linsyhjae distinctclinicalfeaturesandnovelmutationsintaiwanesepatientswithxlinkedagammaglobulinemia